Native Versus Allograft BK Polyomavirus Nephropathy: A Matched Cohort Study of Clinicopathological Features and Outcomes.

Authors

Tong Wu, Shicong Yang, Ling Hong, Xianghong He, Qihua Wang, Jue Wang, Zeying Jiang, Zhixin Huang, Daiwen Lu, Gang Huang, Wenfang Chen

Published in

Clinical transplantation. Volume 40. Issue 9. Pages e70693.

Abstract

BK polyomavirus nephropathy (BKPyVN) is a well-recognized cause of graft dysfunction and loss in kidney transplant recipients (KTRs). However, its clinical and pathological features in the native kidneys of non- KTRs remain poorly defined. We aimed to characterize native-kidney BKPyVN and compare it with allograft BKPyVN.
We retrospectively analyzed the clinical, virological, pathological and prognostic features of native-kidney BKPyVN. A 1:4 matched cohort of KTRs with allograft BKPyVN served as the control group. Diagnosis was established by kidney biopsy with SV40-T immunohistochemical confirmation and supported by BKPyV DNA detection in urine and/or plasma.
Nine patients with native-kidney BKPyVN were identified, including 6 who had undergone hematopoietic stem cell transplantation, 2 lung and 1 heart-lung transplantation. All underwent kidney biopsy for progressive kidney dysfunction. At diagnosis, all had marked BKPyV DNAviruria, and plasma BKPyV DNA was detectable in 8 of 9 patients. Tubular basement membrane (TBM) C4d staining was observed in 8 of 9 cases and correlated with the extent of tubular SV40-T positivity. Compared with allograft BKPyVN, native-kidney BKPyVN presented with higher plasma BKPyV DNA levels, greater intrarenal viral load and more severe tubulointerstitial injury (all p < 0.05). Kaplan-Meier analysis showed lower 12-month ESRD-free survival in patients with native-kidney BKPyVN than in those with allograft BKPyVN (p = 0.001).
Native-kidney BKPyVN is associated with advanced tubulointerstitial injury, frequent TBM C4d deposition and poor short-term renal outcomes. The greater severity than allograft BKPyVN may largely reflect delayed diagnosis in the absence of routine BKPyV surveillance. Earlier BKPyV testing and timely kidney biopsy should be considered in high-risk patients with otherwise unexplained kidney dysfunction.

PMID:
42767667
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.